View Printer-Friendly PDF

A Drug Development & Outsourcing Profile

Acasti Pharma Inc.

100-545 Promenade du Centropolis
Laval QC  H7T 0A3
Canada

  • Tel: 450-686-4555x405
  • 855-314-5747
  • Fax: 450-686-2505
  • Mgmt: Pierre Lemieux
  • COO: Pierre Lemieux
  • R&D: Pierre Lemieux
  • Licng: Pierre Lemieux
  • Est: 2008 - Public
  • Rev: $1–5 M
  • Staff: 10–50
  • Research & Dev.
  • Clinical Research
  • Phase III
  • Business Development
  • Drug Development

Acasti Pharma is a biopharmaceutical innovator advancing a potentially best-in-class cardiovascular drug, CaPre® (omega-3 phospholipid), for the treatment of hypertriglyceridemia, a chronic condition affecting an estimated one third of the U.S. population.

Mfg: No   Labs: Yes

TSX: ACST

0.0248